Burkitt Leukemia: Clinical Trials

3 trials for Burkitt Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Completed 1, Not yet recruiting 1

Follow Burkitt Leukemia: new trials by email Literature Review of Burkitt Leukemia trials Research Report on Burkitt Leukemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Biospecimen Collection, Bone Marrow Aspiration - Acute Biphenotypic Leukemia, Acute Leukemia
Phase 2Not yet recruitingFred Hutchinson Cancer Center522027-01-012026-09-14
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Total-Body Irradiation, Thiotepa, Fludarabine - Acute Biphenotypic Leukemia, Acute Leukemia
Phase 2Active not recruitingFred Hutchinson Cancer Center452019-08-292026-09-25
Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Cyclophosphamide, Cytarabine, Dexamethasone - Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission
Phase 2CompletedM.D. Anderson Cancer Center722011-07-122021-05-03

Narrower conditions

Burkitt Lymphoma (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Blastic Plasmacytoid Dendritic Cell Neoplasm (2)  ·  Leukemia, Biphenotypic, Acute (2)  ·  Leukemia, Mast-Cell (2)  ·  GATA2 Deficiency (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Myeloproliferative Disorders (1)

Broader conditions

DNA Virus Infections (3)  ·  Epstein-Barr Virus Infections (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Herpesviridae Infections (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Infections (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma (3)  ·  Lymphoma, B-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Lymphoproliferative Disorders (3)

Interventions

Cyclophosphamide (3)  ·  Methotrexate (2)  ·  Whole-Body Irradiation (2)  ·  fludarabine (2)  ·  Biopsy (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Calcium Dobesilate (1)  ·  Cytarabine (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Specimen Handling (1)  ·  Tacrolimus (1)  ·  Thiotepa (1)  ·  Vincristine (1)

Sponsors

Fred Hutchinson Cancer Center (2)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (3)

Top investigators

Elias Jabbour (1)  ·  Marie Bleakley (1)  ·  Phuong Vo, MD (1)

Results publications

PMID 32589978, PMID 33049057, PMID 34138471, PMID 35622074

NIH funding

P01CA018029 (1), P30CA015704 (1)